project id: TCGA-ESCA; case submitter id: TCGA-LN-A4A8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.2; age at index: 52; days to birth: -19046; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1960; age at diagnosis: 19046; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 472.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 143; days to sample procurement: 0; initial weight: 320.0; portion submitter id: TCGA-LN-A4A8-01A-32; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;